397 related articles for article (PubMed ID: 23082050)
21. Vitamin D biology in heart failure: molecular mechanisms and systematic review.
Meems LM; van der Harst P; van Gilst WH; de Boer RA
Curr Drug Targets; 2011 Jan; 12(1):29-41. PubMed ID: 20795939
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D for infections.
Korf H; Decallonne B; Mathieu C
Curr Opin Endocrinol Diabetes Obes; 2014 Dec; 21(6):431-6. PubMed ID: 25354043
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D as potential baseline therapy for blood pressure control.
Bouillon R
Am J Hypertens; 2009 Aug; 22(8):816. PubMed ID: 19638953
[No Abstract] [Full Text] [Related]
24. Immunomodulatory Function of Vitamin D and Its Role in Autoimmune Thyroid Disease.
Zhao R; Zhang W; Ma C; Zhao Y; Xiong R; Wang H; Chen W; Zheng SG
Front Immunol; 2021; 12():574967. PubMed ID: 33679732
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D and cancer: a review of molecular mechanisms.
Fleet JC; DeSmet M; Johnson R; Li Y
Biochem J; 2012 Jan; 441(1):61-76. PubMed ID: 22168439
[TBL] [Abstract][Full Text] [Related]
26. Vitamin d and physical performance.
Moran DS; McClung JP; Kohen T; Lieberman HR
Sports Med; 2013 Jul; 43(7):601-11. PubMed ID: 23657931
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D insufficiency: implications for the immune system.
Baeke F; Gysemans C; Korf H; Mathieu C
Pediatr Nephrol; 2010 Sep; 25(9):1597-606. PubMed ID: 20180136
[TBL] [Abstract][Full Text] [Related]
28. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
[TBL] [Abstract][Full Text] [Related]
29. Impaired vitamin D sensitivity.
Máčová L; Bičíková M; Hampl R
Physiol Res; 2018 Nov; 67(Suppl 3):S391-S400. PubMed ID: 30484666
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D and cardiovascular disease.
Norman PE; Powell JT
Circ Res; 2014 Jan; 114(2):379-93. PubMed ID: 24436433
[TBL] [Abstract][Full Text] [Related]
31. The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer.
Krishnan AV; Swami S; Feldman D
Steroids; 2012 Sep; 77(11):1107-12. PubMed ID: 22801352
[TBL] [Abstract][Full Text] [Related]
32. Revisiting the significance of nano-vitamin D for food fortification and therapeutic application.
Jain GK; Raina V; Grover R; Sharma J; Warsi MH; Aggarwal G; Kesharwani P
Drug Dev Ind Pharm; 2024 Feb; 50(2):89-101. PubMed ID: 38175566
[TBL] [Abstract][Full Text] [Related]
33. [Vitamin D and autoimmune thyroid diseases].
Vondra K
Vnitr Lek; 2016; 62(9 Suppl 3):121-125. PubMed ID: 27734704
[TBL] [Abstract][Full Text] [Related]
34. [Vitamin D treatment--which analogs and when?].
Martin PY; Trombetti A; Stoermann C
Ther Umsch; 2007 May; 64(5):237-41. PubMed ID: 17685080
[TBL] [Abstract][Full Text] [Related]
35. New developments in the vitamin D endocrine system.
DeLuca HF
J Am Diet Assoc; 1982 Mar; 80(3):231-7. PubMed ID: 6895759
[TBL] [Abstract][Full Text] [Related]
36. [Vitamin D and kidney diseases].
Cavalier É; Thervet É; Courbebaisse M
Presse Med; 2013 Oct; 42(10):1391-7. PubMed ID: 24055557
[TBL] [Abstract][Full Text] [Related]
37. Maternal vitamin D sufficiency and reduced placental gene expression in angiogenic biomarkers related to comorbidities of pregnancy.
Schulz EV; Cruze L; Wei W; Gehris J; Wagner CL
J Steroid Biochem Mol Biol; 2017 Oct; 173():273-279. PubMed ID: 28216083
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D and kidney disease.
Al-Badr W; Martin KJ
Clin J Am Soc Nephrol; 2008 Sep; 3(5):1555-60. PubMed ID: 18450926
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D control of osteoblast function and bone extracellular matrix mineralization.
van Leeuwen JP; van Driel M; van den Bemd GJ; Pols HA
Crit Rev Eukaryot Gene Expr; 2001; 11(1-3):199-226. PubMed ID: 11693961
[TBL] [Abstract][Full Text] [Related]
40. The 25(OH)Vitamin D Status Affected the Effectiveness of Oligo Fucoidan in Patients with Chronic Hepatitis B Virus Infection with Immune Tolerance Phase.
Ko WS; Shen FP; Shih CJ; Chiou YL
Nutrients; 2020 Jan; 12(2):. PubMed ID: 31991892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
